How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Magnus Heunicke, Minister for Health at the Danish Ministry of Health, argues that one size doesn’t fit all when it comes to Denmark moving towards personalised medicine.
At the University of Freiburg, scientists have created artificial muscles from natural proteins - less Dr Frankenstein, more future potential for reconstructive medicine or soft robotics.
Researchers find that ethnic minority diabetes patients are less likely to take medication for their treatment, due to income differences and lack of access.
A study finds that broad-spectrum antibiotics are prescribed due to a lack of resources for GPs - with "time-consuming microbiological tests" taking too long.
Prof Masahiro Kamitani from the Department of Chemistry at Kitasato University, Japan, introduces recent advances in the development of catalysts for organic synthesis and iron catalysts as alternatives for precious metal catalysts.
Australia has committed to investing heavily in its medical future – but will it be ready for the regenerative medicine revolution? John Gardner from Monash University and Michael Morrison from the University of Oxford provide the answer.
